Business Context and Reporting Period
This Form 8-K Current Report was filed by The Clorox Company (CLX) on January 25, 2021. The filing addresses significant changes to the Company's Board of Directors and corporate governance structure effective February 15, 2021.
Key Financial Metrics
This filing does not contain financial performance data. Revenue, profit, cash flow, margins, debt, and liquidity metrics are not reported in this document.
Material Changes
- Resignation of Executive Chair: Benno Dorer, former CEO and current Executive Chair, notified the Board of his resignation effective February 15, 2021.
- Appointment of Independent Chair: Matthew Shattock was appointed as the new Independent Chair of the Board, effective February 15, 2021.
- Board Member Departure: Pamela Thomas-Graham will not stand for re-election at the end of her term in November 2021 and will step down as Lead Independent Director.
- Committee Leadership Change: Esther Lee was appointed Chair of the Nominating, Governance and Corporate Responsibility Committee, replacing Dr. Richard Carmona.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding operational performance. The primary risk disclosed relates to the transition of leadership roles within the Board of Directors. No unusual items or contingencies were reported.
Investor Verification Checklist
- Verify the effective date of the leadership transition (February 15, 2021).
- Review the attached press release (Exhibit 99.1) for additional context on the Board's strategic direction.
- Confirm the status of the upcoming shareholder meeting regarding Pamela Thomas-Graham's term expiration in November 2021.
- Check subsequent filings for any compensation arrangements related to the departing officers.